4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Pseudomonas Aeruginosa: new trials by email Literature Review of Pseudomonas Aeruginosa trials Research Report on Pseudomonas Aeruginosa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways AZLI - Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 3 | Completed | Gilead Sciences | 61 | 2011-12-01 | 2014-05-29 |
| Second Open Label Extension to Bridging Study CTBM100C2303 Tobramycin inhalation powder - Pulmonary Infections, Pseudomonas Aeruginosa | Phase 3 | Completed | Novartis Pharmaceuticals | 49 | 2010-02-12 | 2021-06-02 |
| Open Label Extension to Bridging Study CTBM100C2303 Tobramycin inhalation powder - Pseudomonas Aeruginosa, Cystic Fibrosis | Phase 3 | Completed | Novartis Pharmaceuticals | 55 | 2009-08-12 | 2021-06-02 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa AZLI 75 mg three times daily (TID), Placebo three times daily (TID) - Cystic Fibrosis, Lung Infection | Phase 3 | Completed | Gilead Sciences | 160 | 2008-05-01 | 2010-12-20 |
Cystic Fibrosis (4) · Pseudomonas Infections (4) · Lung Diseases (2)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Digestive System Diseases (4) · Genetic Diseases, Inborn (4) · Gram-Negative Bacterial Infections (4) · Infant, Newborn, Diseases (4) · Infections (4) · Pancreatic Diseases (4) · Respiratory Tract Diseases (4) · Lung Diseases (2)
Aztreonam (1)
Gilead Sciences (2) · Novartis Pharmaceuticals (2)
Estonia (2) · Russia (2) · United States (2) · Australia (1) · Bulgaria (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Latvia (1) · Lithuania (1) · Poland (1) · Romania (1) · South Africa (1) · Spain (1)
Claire Wainwright, MD (1) · Mark Bresnik, M.D. (1) · Ron Gibson, MD (1)
2008 (1)